MD
January 11 Highlight and Commentary
Chemotherapy-induced neuropathy is a dose-limiting toxicity for many important chemotherapeutic agents, including cisplatin and taxanes such as paclitaxel (Taxol) and docetaxel (Taxotere). Cisplatin produces a sensory neuronopathy with preferential loss of large fiber sensation, while the taxanes produce a symmetric axonal sensorimotor polyneuropathy.1 Over the past decade, several agents have been tested in preventing neuropathy with limited success, i
Evidenced-based medicine????
From Medscape Hematology-Oncology
Marshall on Oncology
Loosening of Medicare Reimbursement for Off-Label Cancer Drugs
Posted 02/03/2009
A Report From the Childhood Cancer Survivor Study
Essential Ingredients in Improving the Efficacy of Standard Cancer Therapy
Numerous articles and several reviews have been published on the role of antioxidants, and diet and lifestyle modifications in cancer prevention.
PET scanning particulary important for multiple myeloma
December 2, 2008 — Scanning with positron emission tomography (PET) scanning has an impact on the intended management of patients with cancer in approximately one third of cases, and new data suggest that this impact is consistent across all cancer types.
The results come from the National Oncologic PET Registry (NOPR), and the latest data are reported in the December issue of the Journal of Nuclear Medicine.
aggressive therapies vs managment?
From the Division of Hematology, Mayo Clinic, Rochester, MN.
Supported in part by grants CA62242, CA85818, CA93842, and CA100080 from the National Cancer Institute, Bethesda, MD.
Individual reprints of this article are not available. Address correspondence to S. Vincent Rajkumar, MD, Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (rajkumar.vincent@mayo.edu).
I have to worry about a secondary cancer AND myeloma?
The 5-year survival rate among patients with cancer is now 66%.[1] For childhood cancer, progress in diagnosis and treatment has transformed a once uniformly fatal disease into a group of malignancies that are now curable in most patients. With the increasing use of risk-based high-intensity therapy and the resulting improvement in survival, the number of cancer survivors is growing rapidly[1]; in the United States, the number of cancer survivors.
Despite the long-held belief by many doctors that discussing end-of-life issues with patients increases the patients' emotional distress, such conversations can actually lead to improved quality of life -- both for patients and their loved ones
Newswise — Despite the long-held belief by many doctors that discussing end-of-life issues with patients increases the patients' emotional distress, such conversations can actually lead to improved quality of life -- both for patients and their loved ones, Dana-Farber Cancer Institute researchers and colleagues have found.
- Myeloma Issues
- 11:30 ET
- Alaka Ray
- all of Dana-Farber; Vicki Jackson
- and Baohui Zhang
- Dana-Farber Cancer Institute
- Dana-Farber research
- Elizabeth Trice
- Fri 03-Oct-2008
- Jennifer Mack
- MD
- MPH
- MS
- of MGH and the Harvard Medical School Center for Palliative Care; Susan Mitchell
- PhD
- racy Balboni
- Susan Block
- END OF LIFE COMMUNICATION ANXIETY BENEFIT QUALITY OF LIFE
e-patients and interactive health communication
This article explores the health care revolution created by the internet, explaining how the Web has helped patients take better care of themselves. It explains that individuals with health care concerns are now able to use the internet as a health resource so they can study up on their disease. Not only is the individual more knowledgeable as a result but sometimes they are able to find better treatments, insist on better health care or even collaborate with medical professionals.